3 employees
Integrated Biosciences combines synthetic biology and machine learning to target cellular stress responses for next-generation therapeutics.
2022
Integrated Biosciences, Inc. raised undisclosed on September 1, 2022
Investors: Root Ventures, Mission BioCapital, Conscience VC, Reinforced Ventures and Polymath Capital Partners